Sara Morrow

1.0k total citations
13 papers, 522 citations indexed

About

Sara Morrow is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Sara Morrow has authored 13 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Sara Morrow's work include Glioma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Sara Morrow is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Sara Morrow collaborates with scholars based in United States, United Kingdom and Italy. Sara Morrow's co-authors include David M. Weinstock, Raphael Koch, Patrick Kelly, Eric S. Fischer, Yasuhiro Oki, T.B. Faust, Pierluigi Porcu, Jacob D. Jaffe, Kerstin Allen and Patricia L. Myskowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Sara Morrow

13 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Morrow United States 6 243 216 203 166 103 13 522
Matko Kalac United States 9 148 0.6× 220 1.0× 89 0.4× 161 1.0× 52 0.5× 37 423
Ewa Paszkiewicz‐Kozik Poland 10 164 0.7× 93 0.4× 97 0.5× 148 0.9× 43 0.4× 57 316
M Wasik Poland 5 181 0.7× 109 0.5× 165 0.8× 114 0.7× 37 0.4× 11 341
Xiaohong Zhao China 5 130 0.5× 233 1.1× 69 0.3× 134 0.8× 22 0.2× 8 376
Bouchra Ghazi Morocco 6 176 0.7× 96 0.4× 175 0.9× 205 1.2× 25 0.2× 22 361
Harald Biersack Germany 13 242 1.0× 219 1.0× 71 0.3× 116 0.7× 72 0.7× 33 560
Chelsia Qiuxia Wang Singapore 12 87 0.4× 228 1.1× 77 0.4× 59 0.4× 98 1.0× 19 451
Elizabeth Kieras United States 11 152 0.6× 53 0.2× 233 1.1× 41 0.2× 34 0.3× 13 420
Yehuda E. Deutsch United States 8 103 0.4× 72 0.3× 52 0.3× 44 0.3× 27 0.3× 23 242
Donatella Amico Italy 6 33 0.1× 97 0.4× 89 0.4× 149 0.9× 23 0.2× 7 278

Countries citing papers authored by Sara Morrow

Since Specialization
Citations

This map shows the geographic impact of Sara Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Morrow more than expected).

Fields of papers citing papers by Sara Morrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Morrow. The network helps show where Sara Morrow may publish in the future.

Co-authorship network of co-authors of Sara Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Morrow. A scholar is included among the top collaborators of Sara Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Morrow. Sara Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lee, Andrew, Scott A. Foster, Sara Morrow, et al.. (2023). Abstract 4914: Role of ClpP in the anti-cancer effects of imipridone ONC201 and ONC206. Cancer Research. 83(7_Supplement). 4914–4914. 1 indexed citations
2.
Morrow, Sara, Yiqun Zhang, Mathew J. Garnett, et al.. (2021). Abstract 393: Predictive biomarker evaluation and molecular differentiation for imipridones ONC201 and ONC206. Cancer Research. 81(13_Supplement). 393–393. 1 indexed citations
3.
Morrow, Sara, Rohinton S. Tarapore, Ailan Guo, et al.. (2021). Abstract 1370: ADME and toxicology profiles of first-in-class DRD2/ClpP-targeted imipridone ONC201. Cancer Research. 81(13_Supplement). 1370–1370. 3 indexed citations
4.
Prabhu, Varun V., Jinkyu Jung, Sara Morrow, et al.. (2020). DDRE-33. MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206. Neuro-Oncology. 22(Supplement_2). ii68–ii68. 1 indexed citations
5.
Prabhu, Varun V., Sara Morrow, Abed Rahman Kawakibi, et al.. (2020). EXTH-74. IND-ENABLING CHARACTERIZATION OF DUAL DRD2- AND ClpP-TARGETING AGENT ONC206 AS THE NEXT IMIPRIDONE FOR CLINICAL NEURO-ONCOLOGY. Neuro-Oncology. 22(Supplement_2). ii103–ii103. 2 indexed citations
6.
Sceneay, Jaclyn, Kristin Wilson, Sara Morrow, et al.. (2019). Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. Cancer Discovery. 9(9). 1208–1227. 110 indexed citations
7.
Layer, Jacob V., John P. Cleary, Alexander J. Brown, et al.. (2018). Parp3 promotes long-range end joining in murine cells. Proceedings of the National Academy of Sciences. 115(40). 10076–10081. 12 indexed citations
8.
Koch, Raphael, Amanda L. Christie, Jennifer L. Crombie, et al.. (2018). Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas. Blood. 133(6). 566–575. 35 indexed citations
9.
Morrow, Sara, et al.. (2018). Methylmercury promotes breast cancer cell proliferation. Toxicology Reports. 5. 579–584. 18 indexed citations
10.
Wang, Eric S., Sara Morrow, T.B. Faust, et al.. (2018). Bruton tyrosine kinase degradation as a therapeutic strategy for cancer. Blood. 133(9). 952–961. 131 indexed citations
11.
Morrow, Sara, Eric W. Wang, Radosław P. Nowak, et al.. (2018). Triple Degradation of BTK, IKZF1 and IKZF3 in B-Cell Malignancies. Blood. 132(Supplement 1). 263–263. 2 indexed citations
12.
Horwitz, Steven M., Raphael Koch, Pierluigi Porcu, et al.. (2017). Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 131(8). 888–898. 204 indexed citations
13.
Morrow, Sara. (2009). A survey of school counselor attitudes regarding animal-assisted interventions. University of New Hampshire Scholars Repository (University of New Hampshire at Manchester). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matko Kalac Breakdown of academic impact, for papers by Ewa Paszkiewicz‐Kozik Breakdown of academic impact, for papers by M Wasik Breakdown of academic impact, for papers by Xiaohong Zhao Breakdown of academic impact, for papers by Bouchra Ghazi Breakdown of academic impact, for papers by Harald Biersack Breakdown of academic impact, for papers by Chelsia Qiuxia Wang Breakdown of academic impact, for papers by Elizabeth Kieras Breakdown of academic impact, for papers by Yehuda E. Deutsch Breakdown of academic impact, for papers by Donatella Amico
Rankless by CCL
2026